Endoscope Reprocessing Market Worth $2.15 Billion Shows Impressive Growth in North American Medical Industry

The report analyzes the endoscope reprocessing market by product, end user and region


Northbrook, IL -- (SBWIRE) -- 11/30/2020 -- According to the new market research report "Endoscope Reprocessing Market by Product (High-level Disinfectants & Test Strips, Detergents & Wipes, Automated Endoscope Reprocessors, Endoscope Tracking Systems, Brushes), End User (Hospitals, Ambulatory Surgery Centers) – Global Forecast" published by MarketsandMarkets™.

The Global Endoscope Reprocessing Market is expected to grow at a CAGR of 8.6% to reach to USD 2.15 Billion.

Major Market Growth Drivers:

- High Risk of Infections Associated With Improper Sterilization of Endoscopes
- Increasing Investments, Funds, and Grants By Government Bodies Worldwide
- Rising Number of Hospitals and Growing Hospital Investments in Endoscopy Instruments
- Rising Prevalence of Diseases That Require Endoscopy Procedures

Growth Opportunities:

- Growing Healthcare Market in Emerging Economies
- Increasing Number of Free-Trade Agreements

Browse 65 Market Data Tables and 27 Figures spread through 155 Pages and in-depth TOC | Request Research Sample Pages:

Market Segmentation in Depth:

Automated Endoscope Reprocessors (AERs) to account for the largest share of the endoscope reprocessing market.

On the basis of products, the market is segmented into high-level disinfectants and test strips; detergents and wipes; endoscope tracking systems; endoscope drying, storage, and transport systems; automated endoscope reprocessors (AERs); and other products (brushes and flushing aids, leak testers, hookups, and sponges). The high-level disinfectants and test strips segment is expected to account for the largest share of the global endoscope reprocessing market in 2017. The large share of this segment is attributed to the increasing outbreaks linked to inadequate cleaning or disinfecting during HLD, the effectiveness of high-level disinfectants for quality assurance in decontaminating endoscopes, and rising adherence to endoscope reprocessing guidelines by healthcare centers.

Hospitals segment expected to account for the largest share of the market.

On the basis of end user, the endoscope reprocessing market has been segmented into hospitals, ambulatory surgery centers, and other end users (diagnostic centers, mobile endoscopy facilities, and office endoscopy centers). In 2017, the hospitals segment is expected to account for the largest share of the global endoscope reprocessing market. The ambulatory surgery centers (ASCs) segment, on the other hand, is expected to be the fastest-growing segment during the forecast period. The high growth in this segment can be attributed to the increase in the number of endoscopic procedures performed in ASCs, and rising preference of ASCs over hospitals.

Download PDF Brochure:

North America accounted for the largest share of the endoscope reprocessing market in 2017, followed by Europe. In the US, the endoscope reprocessing market is driven by the favorable reimbursement scenario, rising incidence of cancer, increasing investments by hospitals to purchase new endoscopic equipment, and increasing incidence of endoscope-related infections. In Canada, the growth of the endoscope reprocessing market is driven by the availability of physician bonuses, and implementation of a new funding model for Canadian hospitals.

The various players in the endoscope reprocessing market include Advanced Sterilization Products (ASP) (US), Cantel Medical (US), Laboratories Anios (France), Olympus (Japan), Wassenburg Medical (The Netherlands), Custom Ultrasonics (US), STERIS (US), Steelco (Italy), Getinge (Sweden), ENDO-TECHNIK (Germany), BES Decon (UK), ARC Healthcare Solutions (Canada), and Metrex Research (US) among others.